Cells can carry molecular traces of their donor’s age. Researchers in Bonn have shown that some of those traces can be substantially reset as blood-derived cells are converted into neural stem cells in the laboratory.
In one example highlighted by the University of Bonn, cells from an 80-year-old donor acquired an estimated molecular age below 20. The result concerns cells grown in a dish. It does not mean that the donor became younger, or that the technique reverses aging in a living person. The university’s report describes the finding.
Changing a cell’s identity
The team at University Hospital Bonn and the University of Bonn worked with erythroid progenitor cells, immature precursors of red blood cells. These are different from the mature red blood cells that circulate carrying oxygen.
Reprogramming changes the instructions a cell uses to maintain its identity. In this study, the researchers directly converted blood cell precursors into induced neural stem cells, which can produce cells of the nervous system. The conversion bypassed a fully pluripotent stage, in which cells can give rise to many different tissue types.
The work, led by Lea Jessica Berg and colleagues, was published in Aging Cell on October 3, 2026. It examined cell identity and age-related molecular changes together, rather than treating the appearance of a stem cell as the end of the process. Read the original study.
What a molecular age means
An epigenetic clock estimates age from patterns of chemical marks on DNA. These marks, called DNA methylation, help regulate how genes are used without changing the underlying genetic sequence.
Think of a clock result as a pattern-based estimate, not a literal birthday. A lower number indicates that the measured pattern resembles a younger reference pattern. It does not, by itself, demonstrate that every form of cellular damage has been repaired or that a tissue will work better.
That distinction is especially important when reprogramming also changes what kind of cell is being measured. The authors explicitly describe DNA methylation age as a proxy for biological age, rather than a direct test of age-related cellular dysfunction.
A slow reset researchers can follow
The rejuvenation unfolded gradually over more than 100 days, according to the university’s account. A stem-cell-like appearance emerged before the molecular transition was complete.
This slower timeline is scientifically useful. It gives researchers opportunities to sample the cells at successive stages and ask which changes accompany the falling age estimate. Tracking those steps could help separate the machinery that changes cell identity from the machinery that erases age-associated signatures.
Why it matters for brain research
Blood-derived neural cells offer a route to studying nervous-system biology using accessible donor material. The method may help research into neurodegenerative disease, but its value will depend on the question being asked. Researchers studying diseases of old age need to consider whether resetting age signatures removes features their model is meant to capture.
The next challenge is to connect these molecular changes to meaningful cellular function and understand which parts of the process are necessary. Clinical use would raise additional questions about safety, stability and how cells behave inside the body.
For now, the finding shows that age-associated signatures can change substantially during laboratory cell conversion. It offers a trackable research model of cellular rejuvenation, without establishing a human anti-aging treatment.
Evidence level: Early Research. Laboratory study of human-derived cells; no treatment trial in people.
Source: Berg LJ et al. Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells. Aging Cell (2026). doi:10.1111/acel.70751.